NA Selank Amidate Research Guide: Enhanced Anxiolytic Peptide

Written by NorthPeptide Research Team

For laboratory and research use only. Not for human consumption.

What Is NA Selank Amidate?

NA Selank Amidate is an enhanced analog of the heptapeptide Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), which itself is a synthetic derivative of the endogenous immunomodulatory peptide tuftsin. The “NA” designation indicates N-acetylation — the addition of an acetyl group to the peptide’s N-terminal threonine residue — while “Amidate” refers to C-terminal amidation, where the terminal carboxyl group is converted to a carboxamide.

These two structural modifications serve a specific pharmacological purpose: they protect the peptide from rapid degradation by aminopeptidases (which attack the N-terminus) and carboxypeptidases (which attack the C-terminus). The result is a peptide with substantially greater metabolic stability than unmodified Selank, meaning it remains active in biological systems for longer periods before being broken down.

The same modification strategy is used in NA Semax Amidate — both peptides were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences using this approach to improve the pharmacokinetic profiles of their parent compounds.

How NA Selank Amidate Works

NA Selank Amidate’s mechanism of action mirrors that of Selank but with enhanced duration due to its improved stability. The primary pathways involve:

GABAergic Modulation

Research has demonstrated that Selank and its analogs influence GABAergic neurotransmission. A study published in the Bulletin of Experimental Biology and Medicine found that Selank allosterically modulates GABA-A receptors, enhancing the binding affinity of GABA to its receptor complex (Seredenin et al., 2008). This mechanism is similar in principle to benzodiazepines but without the same degree of sedation or dependence liability observed in preclinical models.

BDNF Expression

Selank peptides have been shown to increase the expression of brain-derived neurotrophic factor (BDNF) in hippocampal neurons. BDNF is a critical protein for neuronal survival, synaptic plasticity, and memory consolidation. A 2009 study found that Selank administration in rodent models resulted in a significant upregulation of BDNF mRNA expression in the hippocampus (Inozemtseva et al., 2009).

Enkephalinase Inhibition

Selank has been identified as an inhibitor of enkephalin-degrading enzymes, which leads to increased levels of endogenous enkephalins — the body’s natural opioid peptides involved in mood regulation and stress response. This mechanism contributes to the anxiolytic effects observed in research settings without directly activating opioid receptors.

Immunomodulatory Effects

Like its parent compound tuftsin, NA Selank Amidate retains immunomodulatory properties. Research indicates it can modulate the expression of interleukin-6 (IL-6) and influence the balance between Th1 and Th2 immune responses. A study in Immunology Letters demonstrated that Selank affected cytokine gene expression patterns in human leukocytes, suggesting a regulatory rather than purely stimulatory immune effect (Ershov et al., 2008).

NA Selank Amidate vs Standard Selank

The key differences between NA Selank Amidate and standard Selank are pharmacokinetic rather than pharmacodynamic:

• Half-life: NA Selank Amidate has a substantially longer active half-life due to protection from terminal peptidases. Standard Selank has a plasma half-life measured in minutes; the modified version persists significantly longer.
• Blood-brain barrier penetration: The acetylation increases lipophilicity, which may improve the peptide’s ability to cross the blood-brain barrier via passive diffusion.
• Core activity: Both peptides engage the same receptor systems and downstream pathways. The modifications do not alter the fundamental mechanism of action — they improve delivery.
• Dosing frequency: The improved stability profile means that in research protocols, NA Selank Amidate may require less frequent administration than standard Selank to maintain consistent peptide levels.

Research Applications

Anxiety and Stress Response

The anxiolytic properties of Selank peptides have been extensively studied in rodent models. The elevated plus maze test, a standard behavioral assay for anxiety, has consistently shown that Selank increases time spent in open arms — indicating reduced anxiety-like behavior — without the motor impairment associated with benzodiazepines (Seredenin & Kozlovskii, 2007). NA Selank Amidate’s improved stability profile makes it of particular interest for studies requiring sustained anxiolytic effects.

Cognitive Function

The combination of BDNF upregulation, GABAergic modulation, and enkephalinase inhibition makes NA Selank Amidate relevant to cognitive research. Studies with standard Selank have demonstrated improvements in learning and memory tasks in rodent models, particularly under conditions of experimentally induced stress. The enhanced compound is of interest for studying whether improved bioavailability translates to enhanced cognitive effects.

Neuroimmune Research

The dual anxiolytic-immunomodulatory profile of Selank peptides is unusual in pharmacology. This makes NA Selank Amidate valuable for researchers studying the neuroimmune axis — the bidirectional communication between the nervous and immune systems. Conditions where anxiety and immune dysfunction co-occur, such as chronic fatigue and autoimmune-related mood disorders, represent active areas of investigation.

Key Research Findings

Study	Key Finding	Reference
GABA-A receptor modulation	Selank enhances GABA binding to GABA-A receptor complex	Seredenin et al., 2008
BDNF expression	Significant upregulation of BDNF mRNA in hippocampus	Inozemtseva et al., 2009
Cytokine modulation	Modulates IL-6 and cytokine gene expression in leukocytes	Ershov et al., 2008
Anxiolytic behavior	Increased open arm time in elevated plus maze without motor impairment	Seredenin & Kozlovskii, 2007

Frequently Asked Questions

What is the difference between Selank and NA Selank Amidate?

NA Selank Amidate contains two structural modifications — N-acetylation and C-terminal amidation — that protect it from enzymatic degradation. The core peptide sequence and mechanism of action are the same. The modifications improve metabolic stability and may enhance blood-brain barrier penetration.

How does NA Selank Amidate compare to NA Semax Amidate?

NA Semax Amidate is a modified version of Semax (an ACTH fragment analog), while NA Selank Amidate is based on tuftsin. Semax is primarily nootropic and neurotrophic; Selank is primarily anxiolytic and immunomodulatory. Both use the same NA-Amidate modification strategy for improved stability. Some researchers study them in combination due to their complementary profiles.

Is NA Selank Amidate more potent than Selank?

The term “potent” is imprecise here. NA Selank Amidate is not necessarily more potent at the receptor level — it engages the same targets. Its advantage is improved bioavailability and duration of action due to greater resistance to enzymatic breakdown. In practical research terms, this can translate to more consistent results with less frequent dosing.